Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
| Conditions: | Cancer |
| Start Date: | October 1, 2007 |
| Phase: | Phase III |
| Status: | Completed |
| NCT ID: | NCT00538850 |
| Study Type: | Interventional |
| Intervention: | Drug: fentanyl sublingual spray|Other: questionnaire administration |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Masking: Double-Blind|Primary Purpose: Supportive Care |
| Results: | No Results Available |
| Sponsors: | Insys Therapeutics Inc |
| Ages: | Adult|Senior |
| Enrollment: | 130 |
| Funded By: | Industry |
| First Received: | October 1, 2007 |
| End Date: | |
| Last Updated: | November 4, 2010 |
| Last Verified: | November 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
